Helicobacter Pylori UFT300 Quick Test
Test and report at the same time
Ultra-fast H. pylori detection from a biopsy The Biohit H. pylori UFT300 is a true quick test for the detection of H. pylori from a biopsy specimen. The biopsy taken during gastroscopy can be tested immediately to diagnose H. pylori infection or to determine the success of eradication therapy. The test results are ready in only 5 minutes enabling diagnosis and reporting at the same time. This saves the patient from an unnecessary visit to the doctor for hearing the test results. The Biohit H. pylori UFT300 quick test has excellent sensitivity and specificity which makes it a highly reliable and accurate tool for diagnostics.
- Ready-to-use test kit
- Cup and plate versions available in kit sizes of 5 and 50 tests
- Results ready in 5 min (both positive and negative)
- Storage in room temperature
- Sensitivity 94,5%, Specificity 100%
- Testing and reporting during one appointment
- 602005PLA (5 tests)
- 602019PLA (50 tests)
- 602019 (50 tests)
- 602021 (100 tests)
N.B In the USA and Japan for research use only. For other countries, please check with your local Biohit distributor.
Helicobacter pylori infection is the most important cause of chronic gastritis. Another mechanism for gastritis and severe atrophic gastritis is the autoimmune mechanism, which can also be triggered by an H. pylori infection. This kit is intended to aid in the diagnosis of H. pylori infection.
Helicobacter pylori is a spiral shaped, gram-negative bacterium that colonizes the human stomach. The organism is found in the mucous layer of the stomach overlying the gastric epithelium and it does not appear to invade tissue. However, the mucosa underneath the area of the H. pylori colonization is invariably inflamed; this condition is referred to as chronic superficial or non-atrophic gastritis, which, if untreated, persists for life. Nevertheless, the chronic inflammatory process can lead to atrophic gastritis, which has been linked with peptic ulceration and gastric cancer, two of the most important diseases of the upper gastrointestinal tract.
The epidemiological evidence of a link between H. pylori infection and gastric adenocarcinoma or mucosa associated lymphoid tissue (MALT) lymphoma has resulted in classification of the organism as a group I carcinogen.